{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:56:00Z","timestamp":1791248160599,"version":"4.1.0"},"reference-count":39,"publisher":"American Association of Avian Pathologists (AAAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Avian Diseases"],"published-print":{"date-parts":[[2024,6,20]]},"abstract":"<jats:p>Nota de Investigaci\u00f3n- La flagelina aumenta la inmunogenicidad de una vacuna subunitaria que contiene lipoprote'\u0131na E de Pasteurella multocida. La enfermedad del c\u00f3lera aviar, causada por la infecci\u00f3n por Pasteurella multocida, representa desaf'\u0131os para la prevenci\u00f3n debido a sus numerosos serotipos. Actualmente, las bacterinas se utilizan ampliamente para la vacunaci\u00f3n contra el c\u00f3lera aviar, pero la protecci\u00f3n se limita a cepas hom\u00f3logas. Las vacunas vivas atenuadas de P. multocida proporcionan cierta protecci\u00f3n heter\u00f3loga, pero los efectos secundarios son considerables. Recientemente, el uso de ant'\u0131genos basados en prote'\u0131nas parece ser prometedor como vacunas subunitarias cuando se ha abordado el problema de su baja inmunogenicidad con adyuvantes eficaces. La flagelina bacteriana se ha considerado ampliamente como un adyuvante prometedor para las vacunas. En este estudio, se analiz\u00f3 la capacidad como adyuvante de la flagelina en una vacuna de subunitaria contra P. multocida en modelos de ratones y pollos. Para la formulaci\u00f3n de la vacuna, el ant'\u0131geno fPlpE (liporote'\u0131na E de P. multocida) se combin\u00f3 con fFliC (flagelina de Salmonella Typhimurium). Las prote'\u0131nas recombinantes de fPlpE y fFliC se expresaron con \u00e9xito utilizando el sistema de E. coli con los tama\u00f1os esperados de 55 kDa y 70 kDa, respectivamente. El fFliC indujo fuertes niveles de expresi\u00f3n de citoquinas proinflamatorias (IL-1\u03b2, IL-8 e IL-6) cuando se estimul\u00f3 en c\u00e9lulas mononucleares de sangre perif\u00e9rica de pollos nativos. La inmunizaci\u00f3n de ratones y pollos con las vacunas subunitarias que contienen fFliC aceler\u00f3 la respuesta de anticuerpos. En las pruebas de desaf'\u0131o, la fFliC aument\u00f3 la eficacia protectora de la vacuna contra la cepa heter\u00f3loga de P. multocida A1 y la cepa altamente virulenta Chu01 en ratones y pollos, respectivamente. Estos datos indicaron posibilidades potenciales de utilizar fFliC como adyuvante inmunoestimulante en el desarrollo de una vacuna subunitaria contra el c\u00f3lera aviar.<\/jats:p>","DOI":"10.1637\/aviandiseases-d-24-00032","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T06:17:46Z","timestamp":1728627466000},"page":"183-191","source":"Crossref","is-referenced-by-count":7,"title":["Flagellin Enhances the Immunogenicity of Pasteurella multocida Lipoprotein E Subunit Vaccine"],"prefix":"10.1637","volume":"68","author":[{"given":"Yao-Chi","family":"Chung","sequence":"first","affiliation":[{"name":"Graduate Institute of Animal Vaccine Technology, College of Veterinary Medicine, National Pingtung University of Science and Technology, 1 Shuefu Road, Neipu, Pingtung 91201, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ting","family":"Cheng","sequence":"additional","affiliation":[{"name":"Graduate Institute of Animal Vaccine Technology, College of Veterinary Medicine, National Pingtung University of Science and Technology, 1 Shuefu Road, Neipu, Pingtung 91201, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yen","family":"Chu","sequence":"additional","affiliation":[{"name":"Graduate Institute of Animal Vaccine Technology, College of Veterinary Medicine, National Pingtung University of Science and Technology, 1 Shuefu Road, Neipu, Pingtung 91201, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haroon","family":"Afzal","sequence":"additional","affiliation":[{"name":"International Degree Program in Animal Vaccine Technology, International College, National Pingtung University of Science and Technology, Pingtung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thu-Dung","family":"Doan","sequence":"additional","affiliation":[{"name":"Graduate Institute of Animal Vaccine Technology, College of Veterinary Medicine, National Pingtung University of Science and Technology, 1 Shuefu Road, Neipu, Pingtung 91201, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1212","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"S Akira, S Uematsu, O Takeuchi,  \"Cell.\"  124, \"Pathogen recognition and innate immunity.\" 783 (2006)","DOI":"10.1016\/j.cell.2006.02.015"},{"key":"2","doi-asserted-by":"crossref","unstructured":"K Al-Hasani, J Boyce, VP McCarl, et al.  \"Microb Cell Fact.\"  6, \"Identification of novel immunogens in Pasteurella multocida.\" 1 (2007)","DOI":"10.1186\/1475-2859-6-3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"AA Kumar, SB Shivachandra, A Biswas, et al.  \"Vet Res Commun.\"  28, \"Prevalent serotypes of Pasteurella multocida isolated from different animal and avian species in India.\" 657 (2004)","DOI":"10.1023\/B:VERC.0000045959.36513.e9"},{"key":"4","doi-asserted-by":"crossref","unstructured":"RB Rimler  and KR Rhoades  \"J Clin Microbiol.\"  25, \"Serogroup F, a new capsule serogroup of Pasteurella multocida.\" 615 (1987)","DOI":"10.1128\/jcm.25.4.615-618.1987"},{"key":"5","doi-asserted-by":"crossref","unstructured":"SB Shivachandra, AA Kumar, R Gautam, et al.  \"Vet J.\"  172, \"Identification of avian strains of Pasteurella multocida in India by conventional and PCR assays.\" 561 (2006)","DOI":"10.1016\/j.tvjl.2005.05.007"},{"key":"6","doi-asserted-by":"crossref","unstructured":"A Dowling, J Hodgson, M Dagleish, et al.  \"Vet Immunol Immunopathol.\"  100, \"Pathophysiological and immune cell responses in calves prior to and following lung challenge with formalin-killed Pasteurella multocida biotype A: 3 and protection studies involving subsequent homologous live challenge.\" 197 (2004)","DOI":"10.1016\/j.vetimm.2004.04.008"},{"key":"7","doi-asserted-by":"crossref","unstructured":"I Hertman, J Markenson, A Michael, et al.  \"Avian Dis.\"  23, \"Attenuated live fowl cholera vaccine. I. Development of vaccine strain M3G of Pasteurella multocida.\" 863 (1979)","DOI":"10.2307\/1589602"},{"key":"8","doi-asserted-by":"crossref","unstructured":"T Hatfaludi, K Al-Hasani, L Gong, et al.  \"PLOS ONE.\"  7, \"Screening of 71 P. multocida proteins for protective efficacy in a fowl cholera infection model and characterization of the protective antigen PlpE.\" e39973 (2012)","DOI":"10.1371\/journal.pone.0039973"},{"key":"9","doi-asserted-by":"crossref","unstructured":"JR Wu, JH Shien, HK Shieh, et al.  \"Vaccine.\"  25, \"Protective immunity conferred by recombinant Pasteurella multocida lipoprotein E (PlpE).\" 4140 (2007)","DOI":"10.1016\/j.vaccine.2007.03.005"},{"key":"10","doi-asserted-by":"crossref","unstructured":"M Schnare, GM Barton, AC Holt, et al.  \"Nat Immunol.\"  2, \"Toll-like receptors control activation of adaptive immune responses.\" 947 (2001)","DOI":"10.1038\/ni712"},{"key":"11","doi-asserted-by":"crossref","unstructured":"B Pulendran, PS Arunachalam, DT O'Hagan,  \"Nat Rev Drug Discov.\"  20, \"Emerging concepts in the science of vaccine adjuvants.\" 454 (2021)","DOI":"10.1038\/s41573-021-00163-y"},{"key":"12","doi-asserted-by":"crossref","unstructured":"B Cui, X Liu, Y Fang, et al.  \"Expert Rev. Vaccines.\"  17, \"Flagellin as a vaccine adjuvant.\" 335 (2018)","DOI":"10.1080\/14760584.2018.1457443"},{"key":"13","doi-asserted-by":"crossref","unstructured":"IA Hajam, PA Dar, I Shahnawaz, et al.  \"Exp Mol Med.\"  49, \"Bacterial flagellin\u2014a potent immunomodulatory agent.\" e373 (2017)","DOI":"10.1038\/emm.2017.172"},{"key":"14","doi-asserted-by":"crossref","unstructured":"SB Mizel  and JT Bates  \"J Immunol.\"  185, \"Flagellin as an adjuvant: cellular mechanisms and potential.\" 5677 (2010)","DOI":"10.4049\/jimmunol.1002156"},{"key":"15","doi-asserted-by":"crossref","unstructured":"F Hayashi, KD Smith, A Ozinsky, et al.  \"Nature.\"  410, \"The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5.\" 1099 (2001)","DOI":"10.1038\/35074106"},{"key":"16","doi-asserted-by":"crossref","unstructured":"AN Honko  and SB Mizel  \"Immunol Res.\"  33, \"Effects of flagellin on innate and adaptive immunity.\" 83 (2005)","DOI":"10.1385\/IR:33:1:083"},{"key":"17","doi-asserted-by":"crossref","unstructured":"IA Hajam, PA Dar, S Chandrasekar, et al.  \"Res Vet Sci.\"  95, \"Co-administration of flagellin augments immune responses to inactivated foot-and-mouth disease virus (FMDV) antigen.\" 936 (2013)","DOI":"10.1016\/j.rvsc.2013.07.021"},{"key":"18","doi-asserted-by":"crossref","unstructured":"TN Truong  and LT Cheng  \"Vaccines.\"  10, \"Development of a Subunit Vaccine against Duck Hepatitis A Virus Serotype 3.\" 523. 2022","DOI":"10.3390\/vaccines10040523"},{"key":"19","doi-asserted-by":"crossref","unstructured":"K Chuekwon, C-Y Chu, L-T Cheng,  \"BMC Vet. Res.\"  18, \"N-terminus of flagellin enhances vaccine efficacy against Actinobacillus pleuropneumoniae.\" 279","DOI":"10.1186\/s12917-022-03380-8"},{"key":"20","doi-asserted-by":"crossref","unstructured":"JJ Treanor, DN Taylor, L Tussey, et al.  \"Vaccine.\"  28, \"Safety and immunogenicity of a recombinant hemagglutinin influenza\u2013flagellin fusion vaccine (VAX125) in healthy young adults.\" 8268 (2010)","DOI":"10.1016\/j.vaccine.2010.10.009"},{"key":"21","doi-asserted-by":"crossref","unstructured":"AF Cunningham, M Khan, J Ball, et al.  \"Eur J Immunol.\"  34, \"Responses to the soluble flagellar protein FliC are Th2, while those to FliC on Salmonella are Th1.\" 2986 (2004)","DOI":"10.1002\/eji.200425403"},{"key":"22","doi-asserted-by":"crossref","unstructured":"S Bobat, A Flores-Langarica, J Hitchcock, et al.  \"Eur J Immunol.\"  41, \"Soluble flagellin, FliC, induces an Ag-specific Th2 response, yet promotes T-bet-regulated Th1 clearance of Salmonella Typhimurium infection.\" 1606 (2011)","DOI":"10.1002\/eji.201041089"},{"key":"23","doi-asserted-by":"crossref","unstructured":"V Le Moigne, G Robreau, W Mahana,  \"Mol Immunol.\"  45, \"Flagellin as a good carrier and potent adjuvant for Th1 response: study of mice immune response to the p27 (Rv2108) Mycobacterium tuberculosis antigen.\" 2499 (2008)","DOI":"10.1016\/j.molimm.2008.01.005"},{"key":"24","doi-asserted-by":"crossref","unstructured":"CT Nguyen, SH Hong, TT Ung, et al.  \"Clin Exp Vaccine Res.\"  2, \"Intranasal immunization with a flagellin-adjuvanted peptide anticancer vaccine prevents tumor development by enhancing specific cytotoxic T lymphocyte response in a mouse model.\" 128 (2013)","DOI":"10.7774\/cevr.2013.2.2.128"},{"key":"25","doi-asserted-by":"crossref","unstructured":"KM Townsend, JD Boyce, JY Chung, et al.  \"J Clin Microbiol.\"  39, \"Genetic organization of Pasteurella multocida cap loci and development of a multiplex capsular PCR typing system.\" 924 (2001)","DOI":"10.1128\/JCM.39.3.924-929.2001"},{"key":"26","unstructured":"\"Instruction Manual.\"  \"Bio-ScaleTM Mini ProfinityTM IMAC Cartridges, 1 and 5 ml\" 11"},{"key":"27","doi-asserted-by":"crossref","unstructured":"LJ Reed  and H Muench  \"Am. J. Epidemiol.\"  27, \"Simple methods of restimating fifty per cent endpoints.\" 493 (1938)","DOI":"10.1093\/oxfordjournals.aje.a118408"},{"key":"28","doi-asserted-by":"crossref","unstructured":"TK Means, F Hayashi, KD Smith, et al.  \"J Immunol.\"  170, \"The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells.\" 5165 (2003)","DOI":"10.4049\/jimmunol.170.10.5165"},{"key":"29","doi-asserted-by":"crossref","unstructured":"JM Zhang  and J An  \"Int Anesthesiol Clin.\"  45, \"Cytokines, inflammation, and pain.\" 27 (2007)","DOI":"10.1097\/AIA.0b013e318034194e"},{"key":"30","doi-asserted-by":"crossref","unstructured":"T Tallant, A Deb, N Kar, et al.  \"BMC Microbiol.\"  4, \"Flagellin acting via TLR5 is the major activator of key signaling pathways leading to NF-\u03baB and proinflammatory gene program activation in intestinal epithelial cells.\" 33 (2004)","DOI":"10.1186\/1471-2180-4-33"},{"key":"31","doi-asserted-by":"crossref","unstructured":"SK Gupta, R Deb, S Gaikwad, et al.  \"Res J Vet Sci.\"  95, \"Recombinant flagellin and its cross-talk with lipopolysaccharide\u2014effect on pooled chicken peripheral blood mononuclear cells.\" 930 (2013)","DOI":"10.1016\/j.rvsc.2013.07.015"},{"key":"32","doi-asserted-by":"crossref","unstructured":"T-D Doan, H-Y Wang, G-M Ke, et al.  \"Vaccines.\"  8, \"N-terminus of flagellin fused to an antigen improves vaccine efficacy against Pasteurella multocida infection in chickens.\" 283","DOI":"10.3390\/vaccines8020283"},{"key":"33","doi-asserted-by":"crossref","unstructured":"SJ McSorley, BD Ehst, Y Yu, et al.  \"J Immunol.\"  169, \"Bacterial flagellin is an effective adjuvant for CD4+ T cells in vivo.\" 3914 (2002)","DOI":"10.4049\/jimmunol.169.7.3914"},{"key":"34","doi-asserted-by":"crossref","unstructured":"A Didierlaurent, I Ferrero, LA Otten, et al.  \"J Immunol.\"  172, \"Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response.\" 6922 (2004)","DOI":"10.4049\/jimmunol.172.11.6922"},{"key":"35","doi-asserted-by":"crossref","unstructured":"MS Hossain, S Ramachandiran, AT Gewirtz, et al.  \"PLOS ONE.\"  9, \"Recombinant TLR5 agonist CBLB502 promotes NK cell-mediated anti-CMV immunity in mice.\" e96165 (2014)","DOI":"10.1371\/journal.pone.0096165"},{"key":"36","doi-asserted-by":"crossref","unstructured":"V Mett, OV Kurnasov, IA Bespalov, et al.  \"Commun Biol.\"  4, \"A deimmunized and pharmacologically optimized Toll-like receptor 5 agonist for therapeutic applications.\" 466 (2021)","DOI":"10.1038\/s42003-021-01978-6"},{"key":"37","doi-asserted-by":"crossref","unstructured":"HC Chaung, LT Cheng, LH Hung, et al.  \"Vet Microbiol.\"  157, \"Salmonella flagellin enhances mucosal immunity of avian influenza vaccine in chickens.\" 69 (2012)","DOI":"10.1016\/j.vetmic.2011.12.014"},{"key":"38","doi-asserted-by":"crossref","unstructured":"L-T Cheng, C-Y Chu, H Vu-Khac, et al.  \"Poult Sci.\"  102, \"Signal sequence contributes to the immunogenicity of Pasteurella multocida lipoprotein E.\" e102200 (2023)","DOI":"10.1016\/j.psj.2022.102200"},{"key":"39","doi-asserted-by":"crossref","unstructured":"M-C Wu, T-D Doan, J-W Lee, et al.  \"Res J Vet Sci.\"  151, \"Recombinant suilysin of Streptococcus suis enhances the protective efficacy of an engineered Pasteurella multocida toxin protein.\" 175 (2022)","DOI":"10.1016\/j.rvsc.2022.08.016"}],"container-title":["Avian Diseases"],"original-title":[],"link":[{"URL":"https:\/\/bioone.org\/journals\/avian-diseases\/volume-68\/issue-3\/aviandiseases-D-24-00032\/Flagellin-Enhances-the-Immunogenicity-of-Pasteurella-multocida-Lipoprotein-E-Subunit\/10.1637\/aviandiseases-D-24-00032.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:33:28Z","timestamp":1791246808000},"score":1,"resource":{"primary":{"URL":"https:\/\/bioone.org\/journals\/avian-diseases\/volume-68\/issue-3\/aviandiseases-D-24-00032\/Flagellin-Enhances-the-Immunogenicity-of-Pasteurella-multocida-Lipoprotein-E-Subunit\/10.1637\/aviandiseases-D-24-00032.full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,20]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,9,1]]}},"URL":"https:\/\/doi.org\/10.1637\/aviandiseases-d-24-00032","relation":{},"ISSN":["0005-2086","1938-4351"],"issn-type":[{"value":"0005-2086","type":"print"},{"value":"1938-4351","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,20]]}}}